ACSG - ETF AI Analysis

Top Page

American Century Small Cap Growth Insights ETF (ACSG)

Rating:67Neutral

Price Target:―

The American Century Small Cap Growth Insights ETF (ACSG) demonstrates a solid overall rating, supported by strong contributions from holdings like Fabrinet (FN) and ATI (ATI). Fabrinet benefits from robust financial performance and strategic board appointments, while ATI shows growth potential in aerospace and defense, despite valuation concerns. However, weaker holdings like Madrigal Pharmaceuticals (MDGL), which faces profitability challenges and high operational costs, slightly weigh down the fund's rating. A key risk factor for this ETF is its exposure to high valuation stocks, which could impact future returns if market conditions shift.

Positive Factors

Strong Sector Balance

The ETF is well-diversified across key sectors like Technology, Health Care, and Industrials, reducing reliance on any single industry.

Healthy Top Holdings Performance

Several top holdings, such as Centrus Energy and Credo Technology, have shown strong year-to-date gains, supporting overall fund performance.

Reasonable Expense Ratio

The ETF's expense ratio is competitive for actively managed funds, helping investors keep more of their returns.

Negative Factors

Overwhelming U.S. Exposure

The ETF is heavily concentrated in U.S. companies, offering limited geographic diversification and exposure to international markets.

Underperforming Holdings

Some top holdings, such as Hayward Holdings and Lumen Technologies, have lagged in performance, potentially dragging down the fund's returns.

Small Asset Base

The ETF has relatively low assets under management, which could lead to less liquidity and higher trading costs for investors.

ACSG vs. SPDR S&P 500 ETF (SPY)

AUM7.05M

RegionNorth America

Expense Ratio0.49%

Beta1.43

IssuerAmerican Century

Inception DateOct 14, 2025

Dividend YieldN/A

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume389

30 Day Avg. Volume911

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

52.84

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering245

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

ACSG Summary

The American Century Small Cap Growth Insights ETF (ACSG) is an actively managed fund that invests in small U.S. companies with strong growth potential. It focuses on industries like technology, healthcare, and industrials, aiming to find hidden opportunities in smaller businesses. Some of its holdings include Credo Technology Group and Centrus Energy. Investors might consider ACSG for its potential to deliver long-term growth and diversify their portfolio with smaller, emerging companies. However, it’s important to note that small-cap stocks can be more volatile than larger companies, meaning their value can fluctuate significantly with market conditions.

How much will it cost me?The American Century Small Cap Growth Insights ETF (ACSG) has an expense ratio of 0.49%, meaning you’ll pay $4.90 per year for every $1,000 invested. This cost is higher than average because the fund is actively managed, which involves more research and decision-making compared to passively managed ETFs that track an index.

What would affect this ETF?The ACSG ETF, focused on U.S. small-cap growth companies, could benefit from innovation and expansion in sectors like technology and healthcare, which make up a significant portion of its holdings. However, it may face challenges during economic downturns, as small-cap stocks are often more volatile and sensitive to interest rate hikes or reduced consumer spending. Regulatory changes or sector-specific disruptions could also impact its performance negatively.

ACSG Top 10 Holdings

The ACSG ETF is leaning heavily into growth-oriented small-cap stocks, with a notable focus on health care and technology, which together make up nearly half of the portfolio. Madrigal Pharmaceuticals is showing promise with strong revenue growth, but its high operational costs and cash burn are holding it back. Fabrinet and ATI are rising stars, benefiting from robust financial performance and bullish momentum, particularly in aerospace and defense. On the flip side, Credo Technology is dragging the fund with mixed results and supply chain challenges. Overall, the fund’s U.S.-centric approach and sector concentration make it a dynamic but potentially volatile play.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
CRDO	Credo Technology Group Holding Ltd	1.41%	$99.61K	$27.27B	88.66%	77 Outperform
FN	Fabrinet	1.11%	$78.12K	$17.71B	104.41%	78 Outperform
BE	Bloom Energy	1.05%	$74.04K	$35.36B	525.00%	62 Neutral
ATI	ATI	1.02%	$71.72K	$16.89B	117.47%	78 Outperform
HXL	Hexcel	0.99%	$70.10K	$6.57B	24.48%	73 Outperform
ATEC	Alphatec Holdings	0.94%	$66.23K	$2.64B	53.33%	57 Neutral
RBC	RBC Bearings	0.89%	$63.13K	$15.77B	59.83%	77 Outperform
HAYW	Hayward Holdings	0.87%	$61.05K	$3.65B	11.59%	73 Outperform
CECO	Ceco Environmental	0.86%	$61.00K	$2.39B	126.49%	72 Outperform
EOSE	Eos Energy Enterprises	0.85%	$60.26K	$5.66B	189.87%	56 Neutral

ACSG Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

41.20

Positive

100DMA

200DMA

Market Momentum

MACD

0.56

Negative

RSI

65.84

Neutral

STOCH

95.12

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ACSG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 42.21, equal to the 50-day MA of 41.20, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.56 indicates Negative momentum. The RSI at 65.84 is Neutral, neither overbought nor oversold. The STOCH value of 95.12 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ACSG.

ACSG Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
ACSG	―	―	$7.05M	0.49%	―
AFSM	―	―	$74.50M	0.75%	―
TMFS	―	―	$70.65M	0.85%	―
SYZ	―	―	$58.70M	0.74%	―
MMSC	―	―	$40.45M	0.95%	―
SAWS	―	―	$3.81M	0.55%	―

Performance Comparison

ACSG

American Century Small Cap Growth Insights ETF

43.36

3.31

8.26%

AFSM

First Trust Active Factor Small Cap ETF

―

TMFS

Motley Fool Small-Cap Growth ETF

―

SYZ

Lazard US Systematic Small Cap Equity ETF

―

MMSC

First Trust Multi-Manager Small Cap Opportunities ETF

―

SAWS

AAM Sawgrass US Small Cap Quality Growth ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents